- The FTSE 100 continued to take advantage of a weaker pound after MPs rejected UK Prime Minister Theresa May's withdrawal agreement.

By the close, the blue-chip index was up 0.6% at 7,279.

Wall Street was a sea of green as investors were optimistic a resolution to the ongoing US-China trade war may be possible.

The Dow Jones rose 0.6% to 25,880 at around 4:45pm UK time.


Travel company TUI slumped 4.4% to 735.6p after it slashed its annual earnings guidance to reflect the cost of having to mitigate for the grounding of its Boeing 737 MAX aircraft.

AstraZeneca shed 5.5% after it revealed plans to raise $3.5bn from a share issue to cut debt and support a $6.9bn collaboration with Daiichi Sankyo to develop a new cancer treatment.

Builders' merchant Travis Perkins added 0.6% on announcing that chief executive John Carter would stand down in August.

He will be replaced by the current CEO of Atkins, Nick Roberts, who would join as a director and CEO designate on 1 July.

Veterinary group CVS jumped 16.1%, despite posting a slump in first-half profit, as it upgraded its outlook for the full year.


Fuller, Smith & Turner said it received regulatory clearance for the £250m sale of its beer business to Asahi and would hold a shareholder vote on the deal next month. Its shares were up 4% at £11.75.

Waste-to-product group Renewi fell 2.7% to 23.5p as it downgraded its annual earnings guidance for the 2020 financial year and said it would cut its dividend.

The bad news was pinned on new regulations for soil treatment in the Netherlands crimping sales.

Professional services group Parity slumped 12% as it downgraded its revenue guidance, having lost a recruitment services contract with the Scottish government.

SkinBioTherapeutics said it had appointed Stuart Ashman to its board as its designated chief executive to replace founder Cath O'Neill. The shares ticked up 0.5% to 16.8p.

Story provided by